Nutritional Status and Functional assessment of Anorexia, Cachexia including Quality of life (QoL) in patients with Gastrointestinal Malignancies undergoing Chemotherapy
Abijah Princy B.1*, Amalorpavamari Lucas2, Merlin Nancy Deepa V.3, Vanitha S.4, Shiny Angel S.5
1Assistant Professor, College of Nursing, CMC, Vellore, Tamil Nadu, India.
2Professor, College of Nursing, CMC, Vellore, Tamil Nadu, India.
3Charge Nurse, Hemato-Oncology Ward, CMC, Vellore, Tamil Nadu, India.
4Chemotherapy Nurse Coordinator, Department of Medical Oncology, CMC, Vellore, Tamil Nadu, India. 5Chemotherapy Nurse Coordinator, Department of Medical Oncology, CMC, Vellore, Tamil Nadu, India.
*Corresponding Author Email: abijah.princyb@cmcvellore.ac.in
ABSTRACT:
Malnutrition is an overlooked domain of concern among patients with GI malignancies especially, while undergoing chemotherapy. Poor nutrition deleteriously impacts treatment outcomes, performance status and eventually the QoL. A quantitative descriptive research approach was used to assess the nutritional status and the functional assessment of anorexia/cachexia including QoL among patients with GI malignancies undergoing chemotherapy. A total of 111 adult patients were enrolled using consecutive sampling technique. Data were collected using PGSGA and FAACT questionnaires. The findings revealed that based on PGSGA, 50.5% were moderately and 23.4% were severely malnourished. 73.90% had a PGSGA point score of ≥ 9. Based on SCRINIO classification, 20.7% were symptomatically cachexic and 58.6% were symptomatic precachexic. Hemoglobin was < 11.9g/dL in 63% of patients. 45% had a performance status (ECOG) score of 1. The overall mean FAACT score was moderate (108.68±22.82). Statistically significant, strong negative correlation existed between nutritional status and FAACT (r=-0.710, p-0.000). Statistically significant difference was found in the mean nutritional status based on ECOG score (p-0.000), SCRINIO classification (p-0.000), hemoglobin level (p-0.001), BMI (p-0.020), family income (p-0.035) and the duration of last chemotherapy received (p-0.035). Also, statistically significant difference was seen in the mean FAACT score based on ECOG score (p-0.000), SCRINIO classification (p-0.000), family income (p-0.001), hemoglobin level (p-0.004) and BMI status (p-0.030). The study reveals that majority of GI cancer patients undergoing chemotherapy are moderately to severely malnourished and have a moderate functional status and QoL. The study emphasizes the critical need for ongoing preemptive nutritional assessment/interventions, improved symptom management and individualized dietary counseling to cancer patients.
KEYWORDS: GI malignancies, Chemotherapy, Nutritional status, Functional assessment of anorexia and cachexia, Quality of life.
INTRODUCTION:
Cancer is a complex disease requiring multimodality treatment approach. Of which, nutrition is a remarkable facet of cancer care. Though important, it is often ignored as attention is paid mostly to definitive cancer therapies such as surgery, chemotherapy, radiation therapy etc. Cancer and cancer therapy significantly predispose patients to malnutrition. Globally, the prevalence of malnutrition among cancer patients ranges between 20% to more than 70% and even up to 85% with differences related to patient age, cancer type and cancer stage.1 Out of all the cancer types, GI malignancies exhibit a higher risk of malnutrition and cachexia due to poor digestive ability and malabsorption.2,3 Further chemotherapy per se can cause anorexia, nausea, vomiting and other GI disturbance worsening the nutritional status. Nutritional impairment in cancer patients paves way for prolonged hospital stay, reduced response to therapy, poor performance status, treatment toxicity, reduced immuno-competence, infections, poor survival and higher healthcare costs.1,4 Eventually, malnutrition has a detrimental effect in the clinical outcomes and quality of survivorship among cancer patients. Therefore, this warrants for periodic clinical screening and evaluation for timely detection and management of malnutrition among cancer patients.
OBJECTIVES:
The objectives of the study were
1. To assess the nutritional status of patients with GI malignancies undergoing chemotherapy
2. To determine the functional assessment of anorexia/cachexia including QoL in patients with GI malignancies undergoing chemotherapy
3. To determine the relationship between nutritional status and functional assessment of anorexia/ cachexia including QoL in patients with GI malignancies undergoing chemotherapy
4. To compare and identify the difference in nutritional status and functional assessment of anorexia/cachexia, including QoL with selected demographic and clinical variables
METHODS:
A descriptive research design was adopted. The sample size was calculated based on statistical inputs (Standard deviation-15.5, precision -3, confidence interval -95%).5 Consecutive sampling technique was used to enroll a sample of 111 patients who were above 18 years, diagnosed with upper/ lower GI malignancies receiving chemotherapy in the Oncology wards and Day care services of a tertiary super specialty hospital in South India. Patients with terminal state of illness, amputated body parts, ongoing uncontrolled infection and acutely ill patients requiring ICU care and those on endovenous albumin infusion or blood transfusion were excluded from the study.
INSTRUMENTS:
The data collection instrument consists of three parts:
Part I had demographic and clinical variables of patients with GI malignancies undergoing chemotherapy which included age, sex, education, occupation, marital status, location, family income, diagnosis, treatment option, chemotherapy protocol, chemotherapy cycle, last date of receiving chemotherapy, BMI, co-morbidities, Eastern Cooperative Oncology Group (ECOG) score, Scrinio working group classification of cancer precachexia/ cachexia and biochemical indices: Hemoglobin and serum albumin. The ECOG Performance Status is a simple measure of functional status. It determines the ability of patient to tolerate therapies in serious illness, specifically for chemotherapy. The scores are as follows: 0-asymptomatic, 1- Symptomatic but completely ambulatory, 2- Symptomatic, <50% in bed during the day, 3- Symptomatic, >50% in bed, but not bedbound, 4- Bed bound, 5- Death.6 Scrinio working group classifies patients with cancer cachexia into asymptomatic precachexia (class 1), symptomatic precachexia (class 2), asymptomatic cachexia (class 3), symptomatic cachexia (class 4) based on weight loss >10%, presence of complaints such as anorexia, fatigue or early satiation.7
Part II included the Scored Patient-Generated Subjective Global Assessment (PG-SGA) questionnaire. PG-SGA is a structured tool developed by Faith Ottery in 2005 to assess the nutritional status in patients with cancer and was last revised in 2020. The Scored PG-SGA has 2 sections: the first section has four patient-generated components (Weight history, food intake, nutrition impact symptoms, activities/function), serves as a screening instrument for nutritional risk/deficit. The second section is completed by a health professional involving six components: 1. Scoring of weight loss 2. Disease and its relation to nutritional requirements 3. Metabolic stress and demand 4. Physical examination 5. Global Assessment categories (A = well nourished, B = moderately malnourished or suspected malnutrition, C = severely malnourished) 6.
The total numerical score and nutritional triage recommendations. PG-SGA point score and triage recommendations:
0-1 No intervention required at this time. Re-assessment on routine and regular basis during treatment.
2-3 Patient and family education by dietitian, nurse, or other clinician with pharmacologic intervention as indicated by symptom survey and lab values as appropriate.
4-8 Requires intervention by dietitian, in conjunction with nurse or physician as indicated by symptoms
≥ 9 Indicates a critical need for improved symptom management and/or nutrient intervention options
Reliability and validity:
PG-SGA has high reliability and validity. The Correlation of PG-SGA score is 0.83 (Cronbach alpha), and kappa value for the agreement of severe malnutrition was 0.78 (all <. 001). The scored PG-SGA showed high sensitivity and specificity (100% and 96.7%, respectively). 8
Part III included Functional Assessment of Anorexia/ Cachexia treatment (FAACT) questionnaire. FAACT questionnaire was developed and published by David Cella D, in 1993 and was revised in 2000. The FAACT tool measures the general aspects of quality of life as well as specific anorexia/cachexia related concerns. It is a structured questionnaire with 39 items. Recall period is 7 days. It has a five point likert scale (0-4). The scoring ranges from 0-156. Higher the score, better the quality of life. FAACT has an internal consistency of 0.87(Cronbach alpha coefficient) and has high validity.9
Data collection procedure:
Ethical clearance was obtained from College of Nursing, Institutional Review Board. Informed written consent was obtained from patients prior to data collection. Data was collected by interview method and by administering the questionnaires. It took about 15-20 minutes per patient. Privacy of the participants and confidentiality of information was maintained throughout the study.
Data analysis:
Descriptive and inferential statistics were used to analyze the data, All statistical analysis were performed using SPSS (IBM® SPSS Statistics version 22.0) and STATA 16.The level of statistical significance was set at p< 0.05. Descriptive statistics was used to summarize the demographic variables, clinical variables, PGSGA score, FAACT score. Pearson’s correlation was used to find the relationship between Nutritional status and FAACT. ANOVA and independent ‘t’ test was used to compare the nutritional status and FACCT with selected demographic and clinical variables.
RESULTS:
1. Demographic and clinical variables:
Majority of the population (70.9%) were males. 43.2% of them belonged to 46-60 years of age. 28.8% of them were under graduates.7.2% were illiterates. Half of the population (51.4%) were employed. 14.4% had a monthly family income of <Rs. 5,000 and 33.3% had a monthly family income of >Rs.30,000. Most of them (91%) were married. 55% of them came from rural areas. The GI malignancies included the stomach (23.4%), colon(20.7%), rectum(18%), pancreas(11.7%) and tongue(8.1%), gall bladder(5.4%), buccal cavity(3.6%), esophagus(3.6%), GE junction(1.8%), rectosigmoid junction(1.8%), appendix(0.9%) and the duodenum(0.9%). The commonly used chemotherapy treatment regimens were CAPOOX(26.1%), FOLFOX(25.2%), FLOFIRI(9.9%) and Paclitaxel Paclitaxel/ Carboplatin (6.3%).59.5% were receiving their first to third cycles of chemotherapy.14.4% received more than 6 cycles of chemotherapy. 41.4% received their last chemotherapy 2 weeks ago. 66.7% of the population had no associated comorbidities.10.8% had Diabetes Mellitus and 9.9% had Hypertension.18% were underweight (BMI of <18.5), 57.7% had a normal BMI(18.5-24.9), 24.3% were pre obese to obese( BMI >25). Hypoalbuminemia was noted in 19.8% (Serum albumin level of <3.4g/dL). 63.1% had Anemia (Hb<11.9g/dL).
2. Performance status of patients with GI malignancies undergoing chemotherapy
Fig 1: Performance status- ECOG score in GI malignancy patients undergoing chemotherapy
Fig 1 depicts that 45% of the population were symptomatic, but were completely ambulatory (ECOG score-1), 2.7% of them were bed bound (ECOG Score-4)
3. Classification of cancer cachexia/ precachexia
Fig 2: Classification of cancer cachexia/ precachexia based on SCRINIO working group
Fig 2 shows that 20.7% were symptomatically cachexic and more than half of them (58.6%) were in symptomatic precachexic state.
4. Nutritional status among GI malignancy patients undergoing chemotherapy
Fig 3: Nutritional status among GI malignancy patients undergoing chemotherapy (Based on PGSGA)
Fig 3 highlights that half of the population (50.5%) were moderately malnourished and 23.4% of the population were severely malnourished
5. PGSGA point score triage category
Table 1: PGSGA point score triage category
|
Sl. No. |
PGSGA Triage scoring category |
No. |
% |
|
1. |
0-1 |
0 |
0.00 |
|
2. |
2-3 |
7 |
6.30 |
|
3. |
4-8 |
22 |
19.80 |
|
4. |
≥ 9 |
82 |
73.90 |
Table 1 shows that majority of them (73.90%) had a PGSGA score of ≥ 9, requiring a critical need for improved symptom management and/or nutrient intervention options
6. Functional assessment of anorexia/ cachexia and quality of life among GI malignancy patients undergoing chemotherapy
Table 2: Functional assessment of anorexia/ cachexia and quality of life
|
Sl. No. |
FAACT Domains |
FAACT score Mean ± Standard Deviation |
Minimum to maximum possible score range |
|
1. |
Physical well being |
18.57±6.58 |
0-28 |
|
2. |
Social/family well being |
20.41±4.11 |
0-28 |
|
3. |
Emotional well being |
18.18±5.27 |
0-24 |
|
4. |
Functional well being |
18.43±6.50 |
0-28 |
|
5. |
Anorexia/cachexia subscale |
33.09±8.05 |
0-48 |
|
6. |
Total FAACT |
108.68±22.82 |
0-156 |
Table 2 reveals that the mean FAACT score in patients with GI malignancies undergoing chemotherapy is moderate (108.68±22.82), there is moderate mean score in all the FAACT domains including anorexia/cachexia subscale (33.09±8.05).
7. Relationship between nutritional status and functional assessment of anorexia/cachexia treatment in patients with GI malignancies undergoing chemotherapy
Fig 4: Relationship between nutritional status and FAACT in patients with GI malignancies undergoing chemotherapy
Fig 4 reveals that there is a statistically significant, strong negative correlation between nutritional status and FAACT(r=-0.710, p-0.000).
8. Comparison of nutritional status (PGSGA) means with selected demographic and clinical variables
Table 3: Comparison of PGSGA means with selected demographic and clinical variables
|
Sl. No. |
Demographic/ clinical variable |
Overall PGSGA Mean ± Standard Deviation |
t/F value |
p value |
|
1. |
Age 18- 45 years 46-60 years >61 years |
15.29±7.51 14.44±6.54 12.56±6.16 |
1.228** |
0.297 |
|
2. |
Sex Male Female |
13.87±6.37 15.19±7.87 |
0.934* |
0.355 |
|
3. |
Education Illiterate Primary Secondary Higher secondary Graduate Post Graduate |
18.00±7.01 15.65±5.60 12.31±6.61 16.36±5.94
13.75±7.16 14.36±7.81 |
1.362** |
0.245 |
|
4. |
Occupation Unemployed Employed |
13.91±7.08 14.72±6.63 |
0.623* |
0.535 |
|
5. |
Family income <Rs.5000 Rs.5000-Rs.15000 Rs.15000-Rs.30000 >Rs. 30000 |
14.88±7.00 16.75±5.66
11.73±6.41
13.22±7.43 |
3.110** |
0.029* |
|
6. |
Marital status Single Married |
13.10±6.40 14.43±6.88 |
0.620* |
0.547 |
|
7. |
Location Urban Rural |
13.84±6.40 14.69±7.18 |
0.658* |
0.512 |
|
8. |
Last chemotherapy received 1 week 2 weeks 3 weeks 4 weeks Not received |
14.50±4.95 15.85±6.68 11.65±7.19 19.00±7.24 13.65±5.67 |
2.694** |
0.035* |
|
9. |
BMI <18.5 18.5-24.9 >25 |
16.10±6.32 15.05±6.73 11.22±6.65 |
4.040** |
0.020* |
|
10. |
Haemoglobin <11.9g/dL >12g/dL |
15.89±6.630 11.66±6.402 |
3.314* |
0.001** |
|
11. |
Serum albumin <3.4 g/dL 3.5-5.5 g/dL |
16.82±7.61 13.73±6.54 |
1.751* |
0.090 |
|
12. |
ECOG score 0 1 2 3 4 |
8.19±5.28 14.16±5.57 16.81±4.68 25.33±2.73 26.00±4.36 |
21.216** |
0.000** |
|
13. |
SCRINIO classification Asymptomatic precachexia Symptomatic precachexia Asymptomatic cachexia Symptomatic cachexia |
5.70±3.11
15.62±5.42
-
19.22±5.45 |
46.631** |
0.000** |
*t **ANOVA *p<0.05 **p<0.005
Table 3 reveals that there is a high statistically significant difference in the mean nutritional status based on ECOG score (p-0.000), SCRINIO classification (p-0.000), haemoglobin level (p-0.001), BMI (p-0.020), family income (p-0.035) and the duration of last chemotherapy received (p-0.035). The mean nutritional status is significantly better in male patients (13.87±6.37) than in the female patients (15.19±7.87). Nutritional status is lesser among the illiterates (18.00±7.01). Patients with hypoalbuminemia have a lower nutritional status (16.82±7.61) than those with normal serum albumin levels (13.73±6.54).
9. Comparison of functional assessment of anorexia/cachexia including QoL (FAACT) means with selected demographic and clinical variables:
Table 4: Comparison of FAACT means with selected demographic and clinical variables
|
Sl. No. |
Demographic/ Clinical variable |
Overall FAACT Mean ± Standard Deviation |
t/F value |
p value |
|
1. |
Age 18- 45 years 46-60 years >61 years |
104.92±23.25 107.81±24.30 116.08±17.78 |
1.895** |
0.155 |
|
2. |
Sex Male Female |
110.68±22.02 103.97±24.31 |
1.366* |
0.177 |
|
3. |
Education Illiterate Primary Secondary Higher secondary Graduate Post Graduate |
92.63±18.81 106.00±20.79 110.41±23.73 100.45±18.12
115.00±24.59 109.57±21.11 |
1.707** |
0.139 |
|
4. |
Occupation Unemployed Employed |
107.54±23.40 109.77±22.41 |
0.513* |
0.609 |
|
5. |
Family income <Rs.5000 Rs.5000-Rs.15000 Rs.15000-Rs.30000 >Rs. 30000 |
107.06±26.01 96.81±18.60
116.59±24.12
116.24±19.85 |
6.311** |
0.001** |
|
6. |
Marital status Single Married |
109.90±21.45 108.56±23.05 |
0.187* |
0.855 |
|
7. |
Location Urban Rural |
112.10±21.22 105.89±23.86 |
1.450* |
0.150 |
|
8. |
Chemotherapy cycle 1-3 4-6 >6 |
109.71±21.76 102.34±25.64 115.94±20.03 |
2.032** |
0.136 |
|
9. |
Last chemotherapy received 1 week 2 weeks 3 weeks 4 weeks Not received |
133.00±2.83 107.00±21.57 111.52±24.70 95.17±24.61 109.54±22.21 |
1.299** |
0.275 |
|
10. |
BMI <18.5 18.5-24.9 >25 |
99.40±24.50 108.08±21.68 117.00±22.05 |
3.637** |
0.030* |
|
11. |
Haemoglobin <11.99g/dl >12g/dL |
104.16±23.80 116.41±18.91 |
2.989* |
0.004** |
|
12. |
Serum albumin <3.4g/dL 3.5-5.5g/dL |
103.27±27.23 110.06±21.68 |
1.086* |
0.287 |
|
13. |
ECOG score 0 1 2 3 4 |
128.15±15.34 112.76±18.08 92.19±17.00 81.00±14.91 70.33±11.59 |
23.250** |
0.000** |
|
14. |
SCRINIO classification Asymptomatic precachexia Symptomatic precachexia Asymptomatic cachexia Symptomatic cachexia |
132.52±15.26
105.20±20.05
-
94.70±19.16 |
25.472** |
0.000** |
*t **ANOVA *p<0.05 **p<0.005
Table 4 shows that there is a high statistically significant difference in the mean FAACT score based on ECOG score (p-0.000), SCRINIO classification (p-0.000), family income (p-0.001), haemoglobin level (p-0.004) and BMI (p-0.030). However though not statistically significant, age above 61 years have a better FAACT mean score (116.08±17.78) than the lower age groups. Male patients have a better FAACT mean score (110.68±22.02) than the female patients (103.97±24.31). Patients from urban areas (112.10±21.22) have better FAACT mean score than those from rural areas(105.89±23.86). Patients receiving more than 6 cycles of chemotherapy have better FAACT mean score (115.94±20.03).Patients who had received their previous chemotherapy cycle 1 week ago had better FAACT score (133.00±2.83). FAACT mean score was lesser among patients with hypoalbuminemia (103.27±27.23) than with those with normal serum albumin level (110.06±21.68).
DISCUSSION:
The prevalence of malnutrition is high (84.2%) in cancer patients during treatment. [10] This worsens especially when diagnosed with GI related cancers and all the more while battling with the side effects of chemotherapy such as nausea, vomiting, retching, anorexia, malabsorption and cancer cachexia. There is a statistically significant correlation between chemotherapy, cancer and malnourishment.11 The present study highlights that half of the population (50.5%) were moderately malnourished and 23.4% of the population were severely malnourished. A similar study done in Poland among colorectal cancer patients revealed that 73.3% of patients were moderately malnourished and 2.7% were severely malnourished based on PGSGA scale.5 In a study in Thailand, according to PG-SGA global assessment categories, 39% (75) of 195 cancer patients were well nourished, 27% (53) were moderately malnourished and 34% (67) of patients were severely malnourished.12
Furthermore, in a cross-sectional multicentric study in France on 114 metastatic colorectal cancer patients revealed that 65% were malnourished of whom 19% were severely malnourished.13 In a study in Saudi Arabia, 51.8% were malnourished according to the PG-SGA scoring system (Class B and C) and 48.2% were well-nourished (Class A)11. In Silchar, India, nutritional status of cancer patients during treatment was studied in 57 cancer patients using PG-SGA questionnaire. The findings revealed that 15.8% were well nourished, 31.6% were moderately or suspected of being malnourished and 52.6% were severely malnourished.10 These findings suggest that malnutrition is definitely a major problem that requires immediate attention of the health care workers
In the present study, as per SCRINIO classification, 20.7% had symptomatic cachexia and 58.6% fell in symptomatic precachexia group. This reveals that more than half of the symptomatic precachexia population will gradually glide into symptomatic cachexia if not appropriately managed. This finding is congruent with a study done in Poland, among 75 colorectal cancer patients undergoing chemotherapy, of which cachexia was diagnosed in 19 patients (25%) and 56 patients (75%) had precachexia.5 This stresses the need to promptly identify patients who are in cachexic/ precachexic state and provide appropriate nutritional supplements and periodic evaluation.
While assessing the performance status, 45% had an ECOG score of 1 and 2.7% of them had a score of 4. This indicates that nearly half of the population were symptomatic, but were completely ambulatory. In a similar study done in 154 French hospitals, to assess the nutritional status among 1903 cancer patients, it was found that the performance status was 0 or 1 in 49.8%, 2 in 23.7%, 3 or 4 in 19.6%.14 In another prospective study in Brazil, among 60 GI cancer patients assessed the ECOG score at the beginning of chemotherapy treatment. It was found that 78.3% had an ECOG score of 0-1 and 21.7% had a score of 2.15 In a study done by Ting Zhou et al., among 285 cancer patients, 66.4% had an ECOG score of 1 and 25.1% had a score of 2.16
The present study shows that the mean FAACT score is moderate (108.68±22.82), there is moderate mean score in all the FAACT domains. In a similar study by Ziętarska, M. (2017) had a much lower FAACT average score of 78.5, indicating a reduction in the quality of life of the patients in all aspects of functioning 5. In a study in Bangalore, India, it was found that the QoL score before and after chemotherapy was found to be 54.2 + 11.46 and 46.16 + 9.77 respectively. 17
The present study revealed statistically significant, strong negative correlation between nutritional status and FAACT (r=-0.710, p-0.000). This is supported by study done by Abu Zaid et al. (2017) which found that better the nutritional status (lower total mean score of PG-SGA), the higher the QOL of the respondents (high mean score of global health status). This study was done in Malaysia among 42 colorectal cancer patients post surgery. The results revealed that well-nourished patients had statistically significantly better QOL scores on symptom scales: fatigue (p<0.001), nausea and vomiting (p<0.05), and pain (p<0.001) compared to malnourished patients. [18] A systematic review of Medline data base on nutritional status and quality of life in cancer patients revealed that out of the 26 studies reviewed, 24 studies concluded that better nutritional status was associated with better QoL, 1 study showed that better nutritional status was associated with better QoL only in high-risk patients, while 1 study concluded that there was no association between nutritional status and QoL.19
The present study shows statistically significant difference in the mean nutritional status based on ECOG score, SCRINIO classification, haemoglobin level, BMI, family income and the duration of last chemotherapy received. Ziętarska, M (2017) found positive correlation between age and BMI (R = 0.3, p < 0.05) and also between BMI and SGA (R = 0.3, p < 0.05) 5. A study done in Portugal among 265 cancer patients revealed that PG-SGA positively correlated with ECOG (p < 0.01) and negatively correlated with Karnofsky performance status score (p < 0.01) and BMI (p < 0.01). 20 In a study done in Thailand, showed that PG-SGA correlated with weight, percentage of weight loss in one month, body mass index, body fat, and hand grip strength (p < 0.001) respectively.[12] Alsaleh K et al.(2021) found statistically significant association between PGSGA mean with family income and cancer location (p <0.05). 11
The current study also depicted high statistical significant difference in the mean FAACT score based on ECOG score, SCRINIO classification, family income, haemoglobin level and BMI. In a study done in China, patients with ECOG 0–1 had better scores of each domain of FAACT than patients with ECOG ≥2. 16 In Japan 156 gastric patients were assessed with FACT-G scale. The QoL scores were lower in patients with poorer ECOG scores. 21
The above findings warrants for a long term study with a large sample size. A qualitative study can help to further study the perception of QoL and nutritional needs in Cancer patients. A study can also be done to assess the knowledge level of Health care providers on nutritional management and cancer cachexia assessment/prevention.
CONCLUSION:
The study unfolds the grim reality that most of the GI malignancy patients undergoing chemotherapy are moderately to severely malnourished. Alarmingly, a large number of patients fall into symptomatic precachexia and symptomatic cachexia. Only a moderate level of FAACT score is noted in these patients. This emphasizes the need for prompt ongoing nutritional evaluation and interventions to foster better treatment response and QoL in patients. Oncology nurses play a crucial role not only in rendering definitive cancer therapy but must also pay careful attention in timely assessing, monitoring, educating and intervening to the nutritional and functional needs of cancer patients undergoing chemotherapy.
CONFLICTS OF INTEREST:
There are no conflicts of interest.
REFERENCE:
1. Marshall KM, Loeliger J, Nolte L, Kelaart A, Kiss NK. Prevalence of malnutrition and impact on clinical outcomes in cancer services: A comparison of two time points. Clin Nutr. 2019 Apr;38(2):644–51.
2. Mascaretti F, Evangelista J. Nutritional Assessment in Gastrointestinal Tumors: News from the 2020 ASCO and ESMO World GI Meetings. Gastrointestinal Disorders. 2020 Sep;2(3):310–7.
3. Jamshidi S, Hejazi N, Zimorovat AR. Nutritional Status in Patients with Gastrointestinal Cancer in Comparison To Other Cancers In Shiraz, Southern Iran: a Case-Control Study. World J Plast Surg. 2018 May;7(2):186–92.
4. Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017 Oct;36(5):1187–96.
5. Ziętarska M, Krawczyk-Lipiec J, Kraj L, Zaucha R, Małgorzewicz S. Nutritional status assessment in colorectal cancer patients qualified to systemic treatment. Contemp Oncol (Pozn). 2017;21(2):157–61.
6. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982 Dec;5(6):649–55.
7. Bozzetti F, Mariani L. Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group. JPEN J Parenter Enteral Nutr. 2009 Aug;33(4):361–7.
8. Yoo SH, Oh EG, Youn MJ. The Reliability and Validity of Patient-Generated Subjective Global Assessment (PG-SGA) in Stroke Patients. Journal of Korean Academy of Adult Nursing. 2016 Jun 16;21(6):559–69.
9. Ribaudo JM, Cella D, Hahn EA, Lloyd SR, Tchekmedyian NS, Von Roenn J, et al. Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire. Qual Life Res. 2000;9(10):1137–46.
10. Sharma D, Kannan R, Tapkire R, Nath S. Evaluation of Nutritional Status of Cancer Patients during Treatment by Patient-Generated Subjective Global Assessment: a Hospital-Based Study. Asian Pac J Cancer Prev. 2015;16(18):8173–6.
11. Alsaleh K, Almomen FA, Altaweel A, Barasain O, Alqublan A, Binsalamah A, et al. Malnutrition in cancer patients receiving chemotherapy in a single oncology center. Journal of Nature and Science of Medicine. 2021 Apr 1;4(2):170.
12. Nitichai N, Angkatavanich J, Somlaw N, Voravud N, Lertbutsayanukul C. Validation of the Scored Patient-Generated Subjective Global Assessment (PG-SGA) in Thai Setting and Association with Nutritional Parameters in Cancer Patients. Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1249–55.
13. Barret M, Malka D, Aparicio T, Dalban C, Locher C, Sabate J-M, et al. Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study. Oncology. 2011;81(5–6):395–402.
14. Zhao W, Shi HP. The Prevalence of Malnutrition in Patients Suffering from Different Cancers by Three Classification Methods (P05-041-19). Curr Dev Nutr. 2019 Jun 13;3(Suppl 1):nzz030.P05-041-19.
15. da Rocha IMG, Marcadenti A, de Medeiros GOC, Bezerra RA, Rego JF de M, Gonzalez MC, et al. Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study. J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):445–54.
16. Zhou T, Yang K, Thapa S, Fu Q, Jiang Y, Yu S. Validation of the Chinese version of functional assessment of anorexia-cachexia therapy (FAACT) scale for measuring quality of life in cancer patients with cachexia. Support Care Cancer. 2017 Apr;25(4):1183–9.
17. Prathima S, Murthy M, Maka VV, Paibhavi PR, Reddy H, Vungarala S. Assessment of nutritional status and quality of life among cancer patients undergoing chemotherapy. Annals of Oncology. 2019 Nov 1;30:ix149–50.
18. Zaid ZA, Jackson K, Phd L, Kandiah M. Relationship between quality of life and nutritional status in colorectal cancer patients undergoing chemotherapy. Malaysian Journal of Nutrition. 2017 Jan 1;23:375–84.
19. Lis CG, Gupta D, Lammersfeld CA, Markman M, Vashi PG. Role of nutritional status in predicting quality of life outcomes in cancer--a systematic review of the epidemiological literature. Nutr J. 2012 Apr 24;11:27.
20. Santos IM, Mendes L, Carolino E, Santos CA. Nutritional Status, Functional Status, and Quality of Life - What is the Impact and Relationship on Cancer Patients? Nutr Cancer. 2020 Oct 29;1–14.
21. Maeda H, Sato M, Kobayashi M, Takiguchi N, Yoshikawa T, Yoshino S, et al. Validity of the Japanese version of functional assessment of cancer therapy-gastric (FACT-Ga) and its sensitivity to ascites volume change: a retrospective analysis of Japanese clinical trial participants. Support Care Cancer. 2016 Nov;24(11):4515–21.
Received on 29.12.2021 Modified on 19.02.2022
Accepted on 27.03.2022 ©A&V Publications All right reserved
Asian J. Nursing Education and Research. 2022; 12(2):201-207.
DOI: 10.52711/2349-2996.2022.00040